http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0204391-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14
filingDate 2001-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f22511efeb5102b36352285691dab1d9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07439dcce47b78cf96450caf17cd2ceb
publicationDate 2003-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HU-0204391-A2
titleOfInvention The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
abstract The present invention relates to the use of mirtazapine for the preparation of a pharmaceutical composition for treating a sleep disorder in a subject comprising administering mirtazapine in a unit dosage form containing from 0.1 to 5 mg mirtazapine. The present invention also provides a package for treating sleep disorders in a single patient. SHE
priorityDate 2000-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419495549
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5391
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID407174045
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415830121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134664

Total number of triples: 23.